First-line nivolumab + ipilimumab in Asian patients with advanced NSCLC and high TMB (≥ 10 mut/Mb): Results from CheckMate 227 Meeting Abstract
| Authors: | Park, K.; Lee, J.; Sakai, H.; Lee, K.; Ohe, Y.; Kim, S.; Fukuhara, T.; Kang, J.; Yu, C.; Daga, H.; Hotta, K.; Yokoyama, T.; Tanaka, H.; Takeda, M.; Hellmann, M.; Sheng, J.; Nathan, F.; Yang, R.; Nishio, M. |
| Abstract Title: | First-line nivolumab + ipilimumab in Asian patients with advanced NSCLC and high TMB (≥ 10 mut/Mb): Results from CheckMate 227 |
| Meeting Title: | IASLC Asia Conference on Lung Cancer 2018 |
| Keywords: | ipilimumab; non-small cell lung; nivolumab; cancer; tumor mutational burden |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 12 Suppl. |
| Meeting Dates: | 2018 Nov 7-10 |
| Meeting Location: | Guangzhou, China |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-12-01 |
| Start Page: | S1048 |
| Language: | English |
| ACCESSION: | WOS:000452742800012 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2018.10.021 |
| Notes: | Meeting Abstract: OA11 -- Source: Wos |
